Flinton Capital Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$636K Hold
12,992
0.02% 403
2019
Q2
$677K Sell
12,992
-1,664
-11% -$83.8K 0.02% 402
2019
Q1
$727K Buy
14,656
+1,664
+13% +$74.9K 0.02% 362
2018
Q4
$470K Buy
12,992
+320
+3% +$13.4K 0.02% 439
2018
Q3
$647K Buy
12,672
+2,432
+24% +$108K 0.02% 418
2018
Q2
$379K Hold
10,240
0.01% 503
2018
Q1
$387K Hold
10,240
0.01% 483
2017
Q4
$332K Buy
10,240
+1,280
+14% +$40.7K 0.01% 535
2017
Q3
$271K Buy
8,960
+1,152
+15% +$34.2K 0.01% 539
2017
Q2
$229K Buy
7,808
+3,584
+85% +$98K 0.01% 547
2017
Q1
$107K Buy
4,224
+384
+10% +$9.91K ﹤0.01% 615
2016
Q4
$99K Buy
+3,840
New +$101K ﹤0.01% 597

Other funds holding TECH

Flinton Capital Management's TECH Position: Q3 2019 in Review

Flinton Capital Management held its Bio-Techne (TECH) position steady in Q3 2019 at 12,992 shares worth $636K. The position accounts for 0.02% of the portfolio, ranked #403.

Flinton Capital Management first reported a position in TECH in Q4 2016 and has held it in 12 quarters since. The position peaked at $727K in Q1 2019. 340 funds tracked by Wall St. Rank hold TECH as of Q3 2019.

  • Flinton Capital Management held 12,992 shares of Bio-Techne worth $636K as of Q3 2019.
  • Flinton Capital Management left its Bio-Techne share count unchanged in Q3 2019.
  • Bio-Techne made up 0.02% of Flinton Capital Management's portfolio in Q3 2019, its #403 holding.
  • Flinton Capital Management first reported a position in Bio-Techne in Q4 2016 and has held it in 12 quarters since.
  • Flinton Capital Management's Bio-Techne position peaked at $727K in Q1 2019.
  • 340 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2019.

Based on Flinton Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.